Doença pulmonar obstrutiva crônica


Autoria(s): Cavalcanti, Deborah Maciel; Alves Do Vale, Simone; Tanni, Suzana Erico; De Godoy, Irma
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/12/2004

Resumo

The chronic obstructive lung disease is reviewed with emphasys on its epidemiology and risk factors. The diagnosis, clinical aspects pulmonary, functional alterations and laboratorial findings are discussed. The treatment is also reviewed, based on the actual consensus, considering the following classes of approaches: bronchodilators, inhaled β-agonists, corticoids, methilxanthines, prolonged domiciliar-orygen therapy.

Formato

21-27

Identificador

http://www.moreirajr.com.br/revistas.asp?fase=r003&id_materia=2851

Revista Brasileira de Medicina, v. 61, n. SPEC. ISS., p. 21-27, 2004.

0034-7264

http://hdl.handle.net/11449/68037

2-s2.0-12944293064

Idioma(s)

por

Relação

Revista Brasileira de Medicina

Direitos

openAccess

Palavras-Chave #Chronic obstructive lung disease #Pulmonary diseases #alpha 1 antitrypsin #aminophylline #beta adrenergic receptor stimulating agent #bronchodilating agent #budesonide plus formoterol #cholinergic receptor blocking agent #corticosteroid #fenoterol #fenoterol plus ipratropium bromide #fluticasone propionate plus salmeterol #formoterol #ipratropium bromide #ipratropium bromide plus salbutamol sulfate #methylxanthine derivative #salbutamol #salmeterol #terbutaline #theophylline #tiotropium bromide #arterial gas #chronic obstructive lung disease #clinical feature #differential diagnosis #drug use #dyspnea #home care #human #laboratory test #lung function test #occupational exposure #oxygen therapy #prevalence #review #risk factor #smoking #spirometry #symptom #thorax radiography
Tipo

info:eu-repo/semantics/article